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H Steven WileyEvery new decade of biology brings with it a change in
outlook driven by new technologies and fresh perspec-
tives. Such is the case for cancer and how we consider
the disease. The advent of molecular biology led to the
identification of altered signaling molecules and 'onco-
genes' that were proposed to drive uncontrolled cell
proliferation [1]. The rise of cell biology and new imaging
and culturing technologies led to the idea that disruptions
in the extracellular environment prime cells for trans-
formation [2]. In the current genomics era, cancer is most
commonly seen as a genetic disorder where an unstable
genome gives rise to a variety of different cell variants that
are selected for proliferation and survival [3]. All of these
views are partially correct, of course, and are simply differ-
ent ways of saying that genetic alterations in cancer cells
result in a loss of growth homeostasis. They also take the
view that molecular changes 'drive' a cell to grow uncon-
trollably, rather than tip the balance from one normal
state (quiescence) to another (proliferation). Underlying
this oversimplification is a profound ignorance of what
controls homeostatic cell growth in the first place and
how specific mutations impact it.
Normal, proliferation-competent cells can accurately
monitor their environment and respond appropriately to
perturbation, whether it is a loss of neighbors or an in-
flammatory stimulus. Cancer cells either proliferate or
refuse to die where and when they should not, which
clearly indicates that they have problems in detecting or
responding to their environment. Thus, an enormous
amount of effort has gone into defining the signaling
pathways that can trigger a proliferative response and
the biochemical mechanisms underlying these pathways.
Far less work has focused on understanding the higher-
order logic of these pathways and the roles played by all
of the components as part of an integrated system. In
other words, we do not really understand how cells
process information and make decisions and thus cannotCorrespondence: steven.wiley@pnnl.gov
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a cell does.Cells as an information-processing machine
Consider the cell as a computer that performs some
useful task that we wish to modify. We know that typing
on a computer’s keyboard will result in the execution of
specific tasks, so we focus on how keyboards work.
Intensive studies will reveal how keystrokes are turned
into electrical signals and routed to different parts of the
computer, but will never tell us how the CPU interprets
the keystrokes as commands or executes some specific
program or subroutine. This same type of knowledge is
crucial for a full understanding of how cancer operates.
A cancer cell receives essentially the same contextual
information as its normal counterparts, but it processes
it in an aberrant way so that it executes the wrong pro-
gram (for example, proliferation). Our current knowledge
is allowing us to diagnose faulty 'keyboards' that send
wrong commands, but not faulty programs or defects in
the cellular 'CPU'. Such errors in information processing
undoubtedly underlay a large fraction of cancers.
Most of the work that has been done on cell informa-
tion processing has focused on transcriptional regula-
tion, mostly because of easily quantified endpoints
(levels of a specific transcript), as well as the availability
of simple model systems, such as yeast cells, that can be
readily manipulated. However, the connection between
levels of transcripts and the functional state of the cell is
complex and poorly defined. In addition, connections
between the different signal input streams and transcrip-
tional activation are poorly understood. Recent work
that integrates different types of ’omics data to under-
stand gene regulatory patterns showed that cells respond
to changes in their environment through a complex
network of genes and proteins, but the 'logic' of these
networks is not apparent [4]. It remains an open ques-
tion whether cell circuits will ever be definable in terms
of some logical architecture or whether their distributedis is an Open Access article distributed under the terms of the Creative
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stand them.
We do know that information processing by cells is
distributed between multiple intercellular components,
such as the cytoskeleton and cell surface receptors, and
can depend on multiple molecular processes that occur
at different scales. For example, specific cell responses
are highly dependent on an extracellular network of
interactions between specific environment components,
such as the extracellular matrix and the presence of spe-
cific cell types. This extracellular information-processing
network is also highly dynamic. Cell-secreted proteases
can activate growth factor precursors or inactive com-
plexes. Conversely, secreted binding proteins can block
the activity of previously active extracellular factors [5].
Extracellular information processing can have a pro-
found effect on cancer progression. For example, CSF-1
produced by breast cancer cells can cause local macro-
phages to release epidermal growth factor that is neces-
sary for their proliferation and migration [6]. What is
unknown, however, is the role of such dependencies in
normal cell functions.
What is normal?
One of the hallmarks of cancer is a loss of the cancer
cells’ dependency on specific growth factors for growth
[1]. When it was discovered that some cancer cells make
their own growth factors in a process known as autocrine
signaling, it was thought that this could be a primary
mechanism underlying cancer. It turned out, however,
that most normal cells also undergo autocrine signaling as
part of their context-detection mechanism [7]. Still, inter-
rupting these 'normal' processes has been shown to be an
effective way to inhibit the growth of cancer cells, suggest-
ing that although aberrant in their overall growth pheno-
type, cancer cells are still highly dependent on many of
the same signaling pathways as their normal counterparts.
Indeed, the degree to which cancers arise from a quanti-
tative imbalance in normal feedback processes rather
than a defect in a central signaling pathway is a critical
issue to address.
One of the essential architectural features of all infor-
mation processing systems is feedback. Signaling path-
ways are known to display numerous positive and
negative feedback loops that combine to define their
overall functional output. Depending on their strength
and pattern of interconnections, these feedback loops
can give rise to a wide range of signaling processes, such
as switch-like or graded responses or even oscillations
[8]. The plethora of feedback mechanisms associated
with even the simplest signaling system suggests that
these are crucial for their information processing func-
tions. Indeed, autocrine signaling has been shown to be
part of a positive feedback system that integratesmultiple extracellular signals into a single output [9].
Feedback also provides robustness and stability to
signaling systems, by preventing too much signaling by
overactive receptors and moderating the effect of poten-
tial inhibitory drugs [10]. From a conceptual level,
dysregulation of feedback control systems would seem
necessary for the development of cancer, yet this area of
research has scarcely been explored.
One of the problems with investigating feedback
control is that it is exceedingly difficult to design, exe-
cute and interpret experiments that modify it. Because
feedback control is intrinsically dynamic, the responsible
proteins, such as phosphatases or proteases, tend to be
expressed at low levels and rapidly turn over [11]; thus,
they are hard to detect. Feedback can also give rise to
non-linear effects dependent on its pattern and magni-
tude, making it almost impossible to predict the effect of
a perturbation unless the system is extremely well
characterized and controlled. It is thus far easier to study
the core components of signaling pathways, even if they
are not the most relevant players. It is always easier to
look for lost keys under the streetlight.
Despite the difficulties in studying recursive feedback
systems and the consequent paucity of data on the role
they play in cell information processing, genetic studies
have shown a strong correlation between loss of key
feedback regulators and cancer [12]. It will be critical to
understand the roles they play in both normal and
cancer cells, not only because of the impact of their loss,
but because manipulating them provides potential new
avenues for more effective cancer therapeutics.References
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